• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Zyprexa I.M. Injection
    / Eli Lilly


    Active Ingredient
    Olanzapine 10 mg / 2 ml

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Vial

    10 ml x 10mg/2ml

    not in the basket chart 22688 26176, 26153

    Dosage

    For I.M. use. Intended for short-term use only, for up to a maximum of three consecutive days. Should not be used in subjects under 18 years of age.
    Elderly patients (>60 years): The recommended starting dose is 2.5-5 mg, Depending on the patient clinical status.
    See prescribing information for full details.


    Indications

    Rapid control of agitation and disturbed behaviors in patients with schizophrenia when oral therapy is not appropriate.


    Contra-Indications

    Known hypersensitivity to any ingredient of the product. Olanzapine is contraindicated in patients with known risk of narrow-angle glaucoma.


    Manufacturer
    Lilly Pharma, Germany
    Licence holder
    CLOSE